Table 2.
Predictive performance of different DL signatures in training and validation sets
| Datasets | Phase | Sensitivity (%) | Specificity (%) | Accuracy (%) | AUC (95%CI) | p value | |
|---|---|---|---|---|---|---|---|
| DL signature | Training set | AP | 76.4 | 84.3 | 82.1 | 0.882 (0.823–0.941) | 0.048* |
| PVP | 67.3 | 85.0 | 80.0 | 0.822 (0.753–0.891) | 0.001* | ||
| HBP | 78.2 | 90.7 | 87.2 | 0.909 (0.860–0.958) | 0.115 | ||
| mp-MR | 76.4 | 93.6 | 88.7 | 0.929 (0.829–0.966) | Ref | ||
| Validation set | AP | 73.9 | 79.1 | 77.8 | 0.826 (0.755–0.897) | 0.019* | |
| PVP | 73.9 | 86.6 | 83.3 | 0.854 (0.780–0.928) | 0.259 | ||
| HBP | 78.3 | 77.6 | 77.8 | 0.888 (0.833–0.943) | 0.743 | ||
| mp-MR | 78.3 | 89.6 | 86.7 | 0.894 (0.811–0.977) | Ref |
AUC, area under the curve; CI, confidence interval; AP, arterial phase; DL, deep learning; PVP, portal venous phase; HBP, hepatobiliary phase; mp-MR, multiple sequences magnetic resonance. p* < 0.05 indicates a significant difference